PRP vs Shockwave for ED: Key Differences

PRP vs Shockwave for ED: Key Differences

man visiting doctor for checkup

Table of Contents

Erectile dysfunction (ED) treatments have evolved beyond medication into regenerative therapies such as Platelet-Rich Plasma (PRP) and low-intensity shockwave therapy (Li-ESWT). Both aim to restore natural erectile function rather than provide temporary assistance, but they differ significantly in mechanism, evidence strength, invasiveness, and clinical adoption.

Overview of PRP and Shockwave Therapy

PRP therapy involves injecting a concentrated form of the patient’s own blood plasma into penile tissue. This plasma contains growth factors that promote tissue repair, angiogenesis (new blood vessel formation), and possibly nerve regeneration.

Shockwave therapy uses low-intensity acoustic waves applied externally to the penis. These waves create controlled microtrauma, which stimulates healing responses, improves blood flow, and enhances vascular function.

Both are classified as regenerative treatments, meaning they target underlying causes of ED, particularly vascular insufficiency, rather than simply improving symptoms.

Mechanism of Action

PRP works biologically through growth factor release. When injected, it delivers high concentrations of platelets that release signaling molecules responsible for tissue repair and vascular regeneration. Animal studies suggest improvements in nerve recovery and erectile function, but human data remains limited.

Shockwave therapy operates mechanically. The acoustic waves induce micro-injuries that trigger angiogenesis and recruit stem cells to damaged tissue. This improves penile blood flow, which is a key factor in achieving and maintaining erections.

Effectiveness and Clinical Evidence

Shockwave therapy has stronger clinical evidence compared to PRP. Multiple randomized controlled trials and meta-analyses show statistically significant improvements in erectile function scores (IIEF) compared to placebo.

PRP, in contrast, has limited human clinical data. Current guidelines classify it as experimental due to insufficient high-quality evidence supporting its routine use.

A recent meta-analysis suggests that combining PRP with shockwave therapy may produce better outcomes than shockwave alone, particularly in improving blood flow and erectile function over several months.

Invasiveness and Procedure Differences

PRP is invasive. It requires:

  • Blood extraction
  • Centrifugation to isolate plasma
  • Direct injection into penile tissue

Shockwave therapy is non-invasive. It involves:

  • External application of a handheld device
  • No injections or anesthesia in most cases
  • Short outpatient sessions

This distinction impacts patient preference, recovery time, and risk profile.

Safety Profile

Shockwave therapy demonstrates a favorable safety profile with minimal reported adverse effects in clinical studies.

PRP is generally considered low-risk because it uses autologous (self-derived) blood. However, risks include:

  • Injection-related discomfort
  • Infection (rare)
  • Lack of standardized protocols

Due to limited evidence, PRP safety and efficacy are not fully established in large-scale human trials.

Treatment Protocols and Duration

Shockwave therapy typically involves multiple sessions (e.g., 1–2 times per week over 3–6 weeks), with gradual improvement over time.

PRP treatment protocols vary widely. Some clinics offer single injections, while others recommend multiple sessions spaced weeks apart. There is no standardized regimen.

Suitability by ED Type

Shockwave therapy is most effective for:

  • Mild to moderate ED
  • Vasculogenic ED (blood flow-related)
  • Patients partially responsive to PDE5 inhibitors (e.g., sildenafil)

PRP may be considered for:

  • Patients seeking regenerative or adjunct therapies
  • Cases involving tissue or nerve damage (theoretical benefit)

However, due to limited evidence, PRP is not widely recommended as a first-line or standalone treatment.

Cost and Accessibility

Shockwave therapy is more widely available and increasingly offered in urology and men’s health clinics.

PRP is less standardized and often marketed under various branded procedures (e.g., “P-Shot”), with pricing and protocols varying significantly.

Both treatments are typically not covered by insurance due to their classification as elective or investigational therapies.

Key Differences Summary

Factor

PRP Therapy

Shockwave Therapy

Type

Injection-based

Non-invasive

Mechanism

Growth factors, tissue regeneration

Acoustic waves, improved blood flow

Evidence strength

Limited, experimental

Moderate, supported by RCTs

Pain/discomfort

Mild to moderate (injections)

Minimal

Standardization

Low

Moderate

Guideline status

Experimental

Investigational but better supported

Combination Therapy

Emerging evidence indicates a synergistic effect when both therapies are combined. PRP enhances cellular regeneration, while shockwave therapy improves tissue responsiveness and circulation. Studies report improved erectile scores and blood flow when both are used together compared to shockwave alone.

However, combination therapy remains investigational and lacks long-term standardized protocols.

Conclusion

Shockwave therapy currently has stronger clinical validation, broader adoption, and a non-invasive profile, making it the more established regenerative option for ED.

PRP remains experimental with limited human data but offers a biologically plausible mechanism for tissue repair.

Combination therapy shows potential but requires further validation through large-scale clinical trials.

Both treatments target underlying causes of ED rather than symptoms, representing a shift toward regenerative urology.

 

Frequently Asked Questions (FAQ)

1. Which is more effective for ED: PRP or shockwave therapy?

Shockwave therapy has stronger clinical evidence, including randomized controlled trials showing improvement in erectile function. PRP lacks sufficient high-quality human studies and remains experimental.

PRP involves injections into penile tissue. Mild to moderate discomfort can occur during and after the procedure. Numbing agents are commonly used to reduce pain.

Clinical studies indicate improvements can last several months to over a year. Duration varies depending on severity of ED and underlying health conditions. Long-term durability beyond this timeframe is still under study.

Yes. Some clinical data suggests combination therapy may improve outcomes compared to shockwave alone. Evidence is limited and not yet standardized.

 

Shockwave therapy is primarily used for mild to moderate vasculogenic ED. PRP may be considered in experimental or adjunct settings. Severe ED or nerve damage cases may not respond effectively.

Have Questions? Call/ Whatsapp Us Now

English / Malay: +6010-662 1332  (Reachable 8am – 12 midnight, 365 days)

Mandarin: +6012-773 2074 (Reachable 10am – 7pm, Monday to Saturday)

Location

Bangsar Branch
Find us on Google Maps

KL City Branch
Find us on Google Maps

Mont Kiara Branch
Find us on Google Maps

Taman Tun Dr Ismail Branch
Find us on Google Maps